Clinical trial
Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody…
NCT00420966 · Sunnybrook Health Sciences Centre, Other · Completed
Key facts
| NCT number | NCT00420966 |
|---|---|
| Title | Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy |
| Official title | Phase IV Study of Respiratory Syncytial Virus Monoclonal Antibody Therapy in High-risk Infants and Toddlers |
| Lead sponsor | Sunnybrook Health Sciences Centre, Other |
| Collaborators | Abbott Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Lower Respiratory Tract Infection, Respiratory Syncytial Virus Infections |
| Enrollment | 25,003 |
| Start date | Oct 1, 2005 |
| Primary completion | Jun 26, 2017 |
| Completion | Jun 26, 2017 |
| First posted | Jan 11, 2007 |
| Last update posted | Apr 17, 2018 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: